Identification of a novel variant CYP2C9 allele in Chinese

Dayong Si, Yingjie Guo, Yifan Zhang, +3

Pharmacogenetics

Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy

Yingjie Guo, Cheng Hu, HE Xiao-jing, +2

Drug Metabolism and Pharmacokinetics

Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells

Zhixin Qiao, Suping Ren, Weijing Li, +7

Biochemical and Biophysical Research Communications

Tumor BiologyPancreatic CancerGemcitabine CytotoxicityMedicinePharmacology +7

ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS

Yingjie Guo, Yifan Zhang, Ying Wang, +5

Drug Metabolism and Disposition

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

Yifan Zhang, Dayong Si, Xiaoyan Chen, +4

British Journal of Clinical Pharmacology

Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy

Hongmei Meng, Guimei Guo, Jinyan Ren, +3

Epilepsy & Behavior

Plasma Carbamazepine ConcentrationsAbcb1 PolymorphismsGenetic EpidemiologyPharmacologyHuman Polymorphism +3

Halloysite Nanotubes, a Multifunctional Nanovehicle for Anticancer Drug Delivery

Mingyi Guo, Aifei Wang, Faheem Muhammad, +4

Chinese Journal of Chemistry

NanoparticlesNanotherapeuticsEngineeringHalloysite NanotubesBiomedical Engineering +14

Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype

Yifan Zhang, Dafang Zhong, Dayong Si, +3

British Journal of Clinical Pharmacology

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

Guan Wang, Jing He, Jianyun Zhao, +9

PLoS ONE

Catalytic activities of human cytochrome P450 2C9*1, 2C9*3 and 2C9*13

Yingjie Guo, Y Wang, Dayong Si, +3

Xenobiotica

Chemical BiologyLower LuminescenceBiochemistryMedicineNatural Sciences +10